Stock listing
NASDAQ:CNCE Concert Pharmaceuticals Inc Stock
Follow Concert Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:CNCE
$8.37 USD
Close on Mar 6, 2023 · No longer trades
- Lowest – highest close
- $2.69 – $29.05 USDSince Feb 13, 2014 · lowest Oct 22, 2021 · highest Dec 19, 2017
Delisted NASDAQ:CNCE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CNCE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Concert Pharmaceuticals Inc on 6ix
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 7, 2022
- Decks
- 4 decks · latest Aug 4, 2022
Events
| Call | When | Status |
|---|---|---|
| Concert Pharmaceuticals (CNCE) Q3 2022 Earnings Call | Mon, Nov 07, 2022 · 8:30 AM ET | Replay |
| Concert Pharmaceuticals (CNCE) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 8:30 AM ET | Replay |
| Concert Pharmaceuticals (CNCE) Q1 2022 Earnings Call | Thu, May 05, 2022 · 8:30 AM ET | Replay |
| Concert Pharmaceuticals (CNCE) Q4 2021 Earnings Call | Thu, Mar 03, 2022 · 8:30 AM ET | Replay |
| Concert Pharmaceuticals (CNCE) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 8:30 AM ET | Replay |
| Concert Pharmaceuticals (CNCE) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:30 AM ET | Replay |
| Concert Pharmaceuticals (CNCE) Q1 2021 Earnings Call | Tue, May 04, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2022) | Investor deck | 22 slides | Aug 4, 2022 |
| Investor Presentation (May 2022) | Investor deck | 17 slides | May 23, 2022 |
| Technical Presentation (September 2019) | Technical | 20 slides | Sep 5, 2019 |
| Merger or Acquisition (April 2017) | Merger or acquisition | 17 slides | Apr 10, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | Director · Mar 13, 2014 – Jun 14, 2018 · Past |
| Richard Aldrich Other companies: KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 3, 2018 · Past); PTC Therapeutics, Inc. (Director · Mar 7, 2013 – Jun 8, 2015 · Past); Tempest Therapeutics, Inc. (Director · Jun 11, 2012 – Dec 7, 2018 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Jun 10, 2014 · Past) | Director · Feb 12, 2014 – Mar 6, 2023 · Past |
| James Cassella Other companies: Trevi Therapeutics, Inc. (Chief Development Officer · Since at least Feb 13, 2020); Alexza Pharmaceuticals Inc (Former EVP, R&D and CSO, Director · Mar 8, 2006 – Jan 23, 2015 · Past) | Chief Development Officer · Feb 2, 2015 – Mar 6, 2023 · Past |
| Wilfred E Jaeger Other companies: Neuronetics, Inc. (Director · Jun 27, 2018 – May 25, 2023 · Past); Nevro Corp (Director · Feb 27, 2018 – May 21, 2020 · Past) | Director · Jun 14, 2018 – Mar 6, 2023 · Past |
| D Ryan Daws Other companies: enGene Therapeutics Inc. (Chief Financial Officer · Since at least Nov 27, 2023) | Chief Financial Officer · Feb 12, 2014 – Jan 4, 2017 · Past |
| Nancy Stuart Other companies: KalVista Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2022) | Chief Operating Officer · Jan 6, 2023 – Mar 6, 2023 · Past |
| Marc A Becker | Chief Financial Officer · Jan 4, 2018 – Mar 6, 2023 · Past |
| Peter Barton Hutt | Director · Jun 9, 2022 – Mar 6, 2023 · Past |
Log in to ask 6ix AI your own questions about Concert Pharmaceuticals Inc.